{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T20:47:24Z","timestamp":1697230044536},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1995,3,1]],"date-time":"1995-03-01T00:00:00Z","timestamp":794016000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur. J. Clin. Microbiol. Infect. Dis."],"published-print":{"date-parts":[[1995,3]]},"DOI":"10.1007\/bf02310366","type":"journal-article","created":{"date-parts":[[2006,2,15]],"date-time":"2006-02-15T08:28:52Z","timestamp":1139992132000},"page":"244-252","source":"Crossref","is-referenced-by-count":4,"title":["Multicentre comparative study on the antibacterial activity of FK-037, a new parenteral cephalosporin"],"prefix":"10.1007","volume":"14","author":[{"given":"J.","family":"Mart\u00ednez-Beltr\u00e1n","sequence":"first","affiliation":[]},{"given":"R.","family":"Cant\u00f3n","sequence":"additional","affiliation":[]},{"given":"J.","family":"Li\u00f1ares","sequence":"additional","affiliation":[]},{"given":"J.","family":"Garc\u00eda de Lomas","sequence":"additional","affiliation":[]},{"given":"C.","family":"Gimeno","sequence":"additional","affiliation":[]},{"given":"F.","family":"Tubau","sequence":"additional","affiliation":[]},{"given":"F.","family":"Baquero","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"BF02310366_CR1","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/BF01964272","volume":"9","author":"A King","year":"1990","unstructured":"King A, Boothman C, Phillips I: Comparative in vitro activity of cefpirome and cefepime, two new cephalosporins. European Journal of Clinical Microbiology & Infectious Diseases 1990, 9: 677\u2013685.","journal-title":"European Journal of Clinical Microbiology & Infectious Diseases"},{"key":"BF02310366_CR2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0732-8893(91)90029-F","volume":"14","author":"RN Jones","year":"1991","unstructured":"Jones RN, Pfaller MA, Allen SD, Gerlach EH, Fuchs PC, Aldridge KE: Antimicrobial activity of cefpirome. An update compared to five third-generation cephalosporins against nearly 6,000 recent clinical isolates from five medical centers. Diagnostic Microbiology and Infectious Disease 1991, 14: 361\u2013364.","journal-title":"Diagnostic Microbiology and Infectious Disease"},{"issue":"Supplement B","key":"BF02310366_CR3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/jac\/32.suppl_B.31","volume":"32","author":"C Thornsberry","year":"1993","unstructured":"Thornsberry C, Brown SD, Yee YC, Bouchillon SK, Marler JK, Rich T: In vitro activity of cefepime and other antimicrobials: survey of European isolates. Journal of Antimicrobial Chemotherapy 1993, 32, Supplement B: 31\u201353.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF02310366_CR4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/jac\/23.1.163","volume":"33","author":"RN Jones","year":"1989","unstructured":"Jones RN, Fuchs PC: Activity of cefepime (BMY 28142) and cefpirome (HR 810) against gram negative bacilli resistant to cefotaxime or ceftazidime. Journal of Antimicrobial Chemotherapy 1989, 33: 163\u2013165.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF02310366_CR5","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1128\/AAC.33.4.498","volume":"33","author":"J Fung-Tomc","year":"1989","unstructured":"Fung-Tomc J, Dougherty TJ, DeOrio FJ, Simich-Jacobson V, Kessler RE: Activity of cefepime against ceftazidime- and cefotaxime-resistant gram-negative bacteria and its relationship to \u03b2-lactamase levels. Antimicrobial Agents and Chemotherapy 1989, 33: 498\u2013502.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02310366_CR6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.7164\/antibiotics.46.71","volume":"46","author":"Y Mine","year":"1993","unstructured":"Mine Y, Watanabe Y, Sakamoto H, Hatano K, Kuno K, Higashi Y, Kamimura T, Matsumoto Y, Tawara S, Matsumoto F: In vitro antibacterial activity of FK-037, a novel parenteral broad-cephalosporin. Journal of Antibiotics 1993, 46: 71\u201387.","journal-title":"Journal of Antibiotics"},{"key":"BF02310366_CR7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1128\/AAC.37.2.301","volume":"37","author":"KP Fu","year":"1993","unstructured":"Fu KP, Foleno BD, Lafredo SC, LoCoco JM, Isaacson DM: In vitro and in vivo antibacterial activities of FK-037, a novel parenteral broad-spectrum cephalosporin. Antimicrobial Agents and Chemotherapy 1993, 37: 301\u2013307.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02310366_CR8","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1128\/AAC.37.3.566","volume":"37","author":"HC Neu","year":"1993","unstructured":"Neu HC, Chin NX, Huang HB: In vitro activity and \u03b2-lactamase stability of FK-037, a parenteral cephalosporin. Antimicrobial Agents and Chemotherapy 1993, 37: 566\u2013573.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02310366_CR9","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1128\/AAC.37.8.1696","volume":"37","author":"JA Washington","year":"1993","unstructured":"Washington JA, Jones RN, Gerlach EH, Murray PR, Allen SD, Knapp CC: Multicenter comparison of in vitro activities of FK-037, cefepime, ceftriaxone, ceftazidime, and cefuroxime. Antimicrobial Agents and Chemotherapy 1993, 37: 1696\u20131700.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02310366_CR10","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/jac\/32.4.654","volume":"32","author":"ML Sanchez","year":"1993","unstructured":"Sanchez ML, Jones RN, and the United States Consortium for Antimicrobial and Surveillance Trials: Antimicrobial activity of FK-037 against class I \u03b2-lactamase producing species resistant to ceftazidime: a multi-laboratory clinical isolate sample. Journal of Antimicrobial Chemotherapy 1993, 32: 654\u2013656.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF02310366_CR11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/jac\/33.1.137","volume":"33","author":"RN Jones","year":"1994","unstructured":"Jones RN, Barrett MS, Erwin ME: In-vitro activity of FK-037, a new cephalosporin. Journal of Antimicrobial Chemotherapy 1994, 33: 137\u2013144.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF02310366_CR12","series-title":"Approved standard","volume-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","author":"National Committee for Clinical Laboratory Standards","year":"1993","unstructured":"National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A3. NCCLS, Villanova, PA, 1993."},{"issue":"Supplement A","key":"BF02310366_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/29.suppl_A.1","volume":"29","author":"REW Hancock","year":"1992","unstructured":"Hancock REW, Bellido F: Factors involved in the enhanced efficacy against gram-negative bacteria of fourth generation cephalosporins. Journal of Antimicrobial Chemotherapy 1992, 29, Supplement A: 1\u20136.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"Supplement B","key":"BF02310366_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/32.suppl_B.1","volume":"32","author":"AF Erhardt","year":"1993","unstructured":"Erhardt AF, Sanders CC: \u03b2-lactam resistance amongstEnterobacter species. Journal of Antimicrobial Chemotherapy 1993, 32, Supplement B: 1\u201311.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF02310366_CR15","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/jac\/32.4.651","volume":"32","author":"HY Chen","year":"1993","unstructured":"Chen HY, Livermore DM: Effects of \u03b2-lactamase inducibility and derepression on the activity of cefepime and cefpirome against gram-negative bacteria. Journal of Antimicrobial Chemotherapy 1993, 32: 651\u2013652.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF02310366_CR16","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1128\/AAC.38.4.898","volume":"38","author":"SK Spangler","year":"1994","unstructured":"Spangler SK, Jacobs MR, Applebaum PC: Susceptibility of 177 penicillin-susceptible and -resistant pneumococci to FK-037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem, and vancomycin. Antimicrobial Agents and Chemotherapy 1994, 38: 898\u2013900.","journal-title":"Antimicrobial Agents and Chemotherapy"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02310366.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02310366\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02310366","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T17:11:55Z","timestamp":1558026715000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02310366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,3]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1995,3]]}},"alternative-id":["BF02310366"],"URL":"https:\/\/doi.org\/10.1007\/bf02310366","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,3]]}}}